FDA Inspection 1125736 — PharmaEssentia US
The FDA completed an inspection of PharmaEssentia US on July 7, 2020 in Burlington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 7, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Burlington, MA (United States)
Additional Details
Sponsor, Contract Research Organization